lobbying_activities: 2349836

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2349836	5265b21a-216c-4cab-8ae6-959dfce98db5	Q3	MASSACHUSETTS MEDICAL SOCIETY	23975	MASSACHUSETTS MEDICAL SOCIETY	2019	third_quarter	PHA	Prescription Drugs H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act S. 340, H.R. 965 - Creating and Restoring Equal Access to Equivalent Samples Act of 2019 CREATES Act of 2019" - promote competition in the market for drugs and biological products by facilitating the timely entry of entry of lower-cost generic and biosimilar versions of those drugs and biological products H.R. 3 - The Lower Drug Costs Now Act S. 99, H.R. 448 - Medicare Drug Price Negotiation Act H.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019 Average Wholesale Price of Pharmaceuticals in Ads - no specific bill H.R. 2113 Prescription Drug STAR Act - Transparency of pharmaceutical prices across all sectors	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		80000	0	0	2019-10-18T10:31:20.037000-04:00